Stroke & Vascular Disorders

Updated 07.23.2023
Released 02.18.2005
Expires For CME 07.23.2026

White matter abnormalities in the brain

Author: Adrian Marchidann MD

Editor: Steven R Levine MD

Introduction

Overview

The presence of white matter abnormalities in the brain of both symptomatic and asymptomatic individuals has been a source of interest for over a century. CT and MRI detection of these lesions has become more sensitive than even autopsy. Clinical studies have associated these lesions with cognitive decline, gait impairment, and increased cerebrovascular disease and death risk. The etiology of white matter abnormalities varies from cerebrovascular disease to metabolic and demyelinating disorders. This article primarily focuses on cerebrovascular disease.

Key points

	• White matter abnormalities are present in at least 10% of individuals older than 65 years of age.
	• These lesions correlate with an increased risk of cognitive impairment, stroke, and death.
	• The causes of white matter abnormalities are many and not fully understood.

Historical note and terminology

In 1894, Binswanger described a male with syphilis who suffered from leg weakness, arm tremors, progressive cognitive decline, including speech and memory, depression, and personality change (12; 13). Although autopsy demonstrated white matter atrophy, Binswanger did not realize the significance of this finding (145). In 1902, Alzheimer described a similar case and attributed the white matter changes to arteriosclerosis of the long, penetrating vessels (02; 146). It was not until 1962 that Binswanger's case was diagnosed as syphilis, and the term “subcortical arteriosclerotic encephalopathy” was proposed to describe cerebral arteriosclerosis affecting vessels of the white matter and subcortical grey matter (124).

CT brain scan, followed by MRI, revealed cerebral white matter changes in both asymptomatic and cognitively impaired individuals (140; 185; 20; 59). These changes appear as hypodensities on CT and are described as white matter lucencies, leukoencephalopathy, or leukoaraiosis. On T2-weighted MRI, these lesions appear hyperintense and are called white matter abnormalities, white matter hyperintensities, cerebral white matter changes, or unidentified bright objects. MRI is more sensitive to these changes (58). Therefore, these white matter changes will be referred to herein as white matter abnormalities.

Clinical manifestations

Presentation and course

	• The burden of white matter abnormalities increases with age.
	• White matter abnormalities may occur in apparently asymptomatic subjects with subtle neurologic deficits.
	• The severity of white matter abnormalities is associated with dementia, depression, risk of falls, cerebrovascular disease, and premature death.

As the quality and availability of MRI increased, so did the number of lesions detected in apparently healthy subjects. Most lesions are lacunar infarcts resulting from hypertensive small vessel disease. Although asymptomatic, the patients may have subtle, often unrecognized, deficits in neurologic function. Moreover, these silent infarcts double the risk of stroke and dementia (166). Abnormal three-step motor sequencing and horizontal extraocular tracking tests can predict the presence of periventricular white matter abnormalities (08).

Cognitive dysfunction. In healthy older adults, white matter abnormalities have been associated with decreased processing speed, memory deficit, and executive and even global cognition dysfunction (37; 68). White matter abnormalities in the temporal and occipital areas were associated with greater age, hypertension, late-onset depression, and cognitive impairment (03).

More severe periventricular white matter abnormalities are associated with Alzheimer disease but cannot be used for diagnosis of dementia (75). Subcortical dementia was seen in patients with severe periventricular white matter abnormalities (70). Frontotemporal dementia also correlates with white matter abnormalities (90). However, similar cognitive decline profiles can be caused by different conditions (164).

Different cognitive patterns were noted in patients with various pathogeneses but similar dementia severity. For example, periventricular white matter abnormalities have been associated with worse comprehension and attention, but white matter abnormalities outside the periventricular area have been associated with worse memory and conceptualization performance (88). The severity of white matter abnormalities correlates with the decline in Wechsler Performance IQ scores, Block Design, Object Assembly, and Digit Symbol tests (56).

Not all cognitive decline is explained by white matter abnormalities. Between the ages of 11 and 78 years, the severity of white matter abnormalities was associated with overall cognition, independent of childhood cognitive ability. However, it was suggested that hypertension accounted for at least a portion of the effects of white matter abnormalities in this study (42).

Balance impairment and risk of falls. Sequential MRI scans performed 20 months apart in elderly subjects have demonstrated a five-fold acceleration of the accumulative volume of white matter abnormalities in individuals with decreased mobility (177). In high-functioning elderly patients, over a period of 4 years, self-reported physical impairment was 22% greater in those with moderate compared to those with minimal white matter abnormality burden (139).

Similarly, patients with Alzheimer disease and white matter abnormalities had a four-fold deterioration of gait compared to normal subjects (57; 102). Additionally, white matter abnormalities were associated with decreased limb power and plantar response as well as rooting and palmomental reflexes (152).

The consequence of impaired balance due to white matter abnormalities is a four-fold increase in the risk of falls compared to controls (86). Conversely, twice as many white matter abnormalities were found in mobility-impaired elderly patients compared to normal controls (71). The presence of ApoE ε4, in addition to white matter abnormalities, has a synergistic effect on standing imbalance (31).

White matter disease in children. White matter abnormalities are also found in children’s brain MRIs. Children younger than 5 years of age with white matter abnormalities and decreased tone had significantly less signal abnormality than the control group or a group of patients with normal tone and presence of white matter abnormalities. The children with increased tone had more white matter abnormalities and hyperreflexia. This suggests that increased signal intensity is more likely associated with spasticity, as compared to those children with normal or low-signal intensity white matter abnormalities in whom normal tone or hypotonia is more likely (95).

Prognosis and complications

Dementia. In nondisabled elderly subjects, severe white matter abnormalities are associated with medial temporal lobe atrophy and a four-fold increase in mild cognitive deficits (159). White matter abnormality severity was associated with reduced global cognition (28).

The burden of white matter abnormalities in early patients with Alzheimer disease cannot be distinguished from that in normal subjects (47). However, severe periventricular white matter abnormalities predict poor neuropsychological performance in patients with Alzheimer disease (75). Moreover, severe white matter abnormalities are associated with faster progression of dementia and mortality; this association is supported by more severe loss of myelinated fibers at autopsy (81).

Progression from mild cognitive impairment to Alzheimer disease can be predicted by white matter abnormalities (175). The risk of dementia increased by 67% for each standard deviation increase in severity of periventricular white matter abnormalities, independent of other brain changes (131).

Silent brain infarcts on baseline MRI were associated with a 126% increased risk of dementia, and psychomotor speed was reduced in those with white matter infarcts. Moreover, cognitive function declined only in those who accrued additional white matter lesions (165).

Depression. Elderly depressed patients had more cerebral atrophy and more severe white matter abnormalities than controls (09). Temporal lobe white matter abnormalities independently predicted the Geriatric Depression Scale, whereas neither a history of stroke nor the number of lacunar infarcts did (122).

Retinopathy and stroke. White matter abnormalities in patients with prior stroke predict an increased risk of subsequent stroke (114; 162). White matter abnormalities are associated with retinal microvascular abnormalities. White matter abnormalities associated with retinopathy predict a significantly higher risk of clinical stroke (20% vs. 1.4%) (178).

Imbalance, impaired gait, and falls. High-functioning elderly patients without stroke or dementia have slower gait and a shorter stride and require longer support time (138). Starkstein and colleagues reported that patients with Alzheimer disease and white matter abnormalities had extrapyramidal signs (151)

Premature death. The risk of death is predicted by advanced white matter abnormalities, even after adjustment for hypertension, high cholesterol, diabetes, and coronary artery disease (87).

Clinical vignette

A 72-year-old male presented with impaired gait. Three years earlier, he was diagnosed with diabetes controlled with oral metformin 500 mg twice daily. For 1 year, his gait had been unstable, as if he was inebriated. He would occasionally catch his toes and fall. Over time, he needed to use the walls for guidance when walking down a hall, and he began to use a cane for mobility assistance. Walking across a dark room was particularly difficult. In addition to gait difficulties, he had become forgetful with daily tasks and sometimes could not recall the names of familiar people.

Past medical, family, and social history were unremarkable. He took no medications. On review of systems, he experienced tingling in both feet, which had become persistent about a year earlier, and he had difficulty sensing temperature if he placed his feet in bathwater.

Examination revealed mild difficulties with verbal memory and moderate to long-term recall of visually identified objects. Language, praxis, and tests of frontal lobe executive functioning were normal. Mini-mental status examination score was 25/30. He had a mild bilateral palmomental reflex. Fundoscopy revealed arteriovenous nicking. Blood pressure was 150/95 mmHg. Visual fields were full. Visual acuity, corrected, was 20/20-2 bilaterally. Pupils and extraocular movements were normal. Strength was normal throughout. Tone was slightly spastic to the left arm and right leg. Reflexes were normal except for bilateral absent ankle jerks. Sensory examination revealed a stocking pattern of pinprick and temperature sensation loss in both feet to the level of the ankle. Vibration and proprioception thresholds were slightly above expected for age at the great toes bilaterally. No dysmetria was present. Gait was narrow-based but slightly staggering; there was no magnetic gait. Tandem gait could not be performed without assistance. Romberg test was slightly positive. No other frontal lobe release signs could be elicited.

Blood tests revealed a random glucose of 12 mmol/L, and hemoglobin A1C was elevated at 7.4%. Nerve conduction studies identified a mild axonal sensory-dominant peripheral neuropathy. MRI of the brain identified numerous white matter abnormalities throughout subcortical regions, along with mild diffuse cerebral atrophy.

White matter abnormalities (FLAIR MRI) (1)

This FLAIR MRI demonstrates white matter abnormalities over periventricular locations as well as over the right anteroinferior corona radiata in the brain of an elderly patient with diabetes and gait abnormality. (Contributed by D...
White matter abnormalities (T2-weighted MRI) (1)

This T2-weighted MRI identifies white matter changes over the more superior right corona radiate in the brain of an elderly patient with diabetes and gait abnormality. (Contributed by Dr. Cory Toth.)

A diagnosis of white matter abnormalities with mild cognitive impairment was made, along with a secondary diagnosis of mild diabetic peripheral neuropathy. Diabetic education was provided. Physical therapy and a walker were recommended for gait difficulties. One year later, worsening mobility led to a fall that caused an epidural hematoma and death.

Biological basis

	• There is a genetic influence in the appearance of white matter abnormalities.
	• Several mechanisms contribute to the etiology of white matter abnormalities: breakdown of the blood-brain barrier, circulating metabolites, impaired metabolite clearance, and decreased cerebral perfusion.
	• Pathology studies reveal loss of axons, myelin, and oligodendrocytes. Thickened blood vessel walls, gliosis, increased interstitial fluid, and edema also occur.

Pathophysiology

Circulating metabolites. Circulating metabolites of both lipid and nonlipid nature, measured by mass spectrometry and high-performance liquid chromatography, correlate with white matter abnormalities in middle-aged and older adults. Hydroxyphenylpyruvate, the most common of these metabolites, explains up to 6% and 14% of the variance in white matter abnormality volume in the pooled sample and in men as compared to hypertension (1%), type 2 diabetes (1% to 3%), or smoking (less than 0.1%). This metabolite is a potentially useful biomarker for white matter abnormalities. In women, glucuronate was the only significantly associated metabolite with white matter abnormalities (148).

Blood-brain barrier disruption. The integrity of the blood-brain barrier may play a role in the etiology of the white matter abnormalities, lacunar stroke, and dementia. Endothelial dysfunction allows leakage of serum components across the small cerebral arteries into the surrounding tissue, leading to neuronal and glial damage. This dysfunction may be intermittent or chronic, or it may occur during hypertensive crisis (171).

Impaired metabolism waste clearance. Clearing the brain of metabolic waste products, including beta-amyloid, alpha-synuclein, and tau protein, is important for homeostasis. Because of the selectivity of the blood-brain barrier, an important amount of cerebral waste drainage occurs through the cerebral spinal fluid via the perivascular spaces created by the astrocytic vascular endfeet. The function of this glymphatic system is increased during nonrapid eye movement sleep (179). Although several perivascular spaces are normal, their number increases with age, hypertension, small vessel disease, amyloid angiopathy, and genetic small-vessel diseases like CADASIL and in neurodegenerative disorders like Alzheimer disease. Uncontrolled hypertension disrupts the smooth flow and leads to amyloid deposition in the perivascular spaces. Increased visibility of perivascular spaces may also be associated with white matter abnormality formation around them (134).

Impaired cerebral perfusion. Diminished perfusion of subcortical white matter correlates with the severity of white matter abnormalities (91). Autoregulation impairment may be responsible for white matter abnormality development (01). Additionally, chronic white matter abnormalities are associated with poor collateral recruitment during stroke caused by large vessel occlusion (99). Moderate to severe white matter abnormalities may be responsible for the worse outcome in patients who undergo mechanical thrombectomy (113).

Neuropathology. Pathological evaluation of white matter abnormalities reveals areas of spongiosis and extracellular space expansion due to loss of axons, myelinated fibers, and oligodendrocytes. Myelin thinning and gliosis are often accompanied by small-vessel atherosclerosis and lacunar infarctions (small cavities). However, fewer white matter abnormalities are visible at autopsy compared with those seen with in-vivo MRI (51; 63).

There is evidence that smooth periventricular white matter abnormalities are different from patchy deep white matter abnormalities. Periventricular capping and leukoaraiosis result from patchy loss of the ependymal cell layer, fibrosis of small vessels and reactive gliosis, increased extracellular fluid content resulting in periependymal edema, axonal atrophy, and decreased myelin (154; 97). However, the myelin rarefaction is not true demyelination, as the process also involves axonal destruction (06; 104).

In a small study, atherosclerosis was present in all types of white matter abnormality but not in all lesions (35). In another study, although periventricular and deep white matter abnormalities were of vascular origin, including microcystic infarcts, the capping and smooth halo were not (52).

In the punctate deep white matter abnormalities, thickening of small vessels, perivascular gliosis, and dilated perivascular spaces were noted (163; 172). Confluent white matter abnormalities indicate more extensive ischemic damage (53). The etiology of white matter abnormalities may be transient repeated events of local hypoperfusion that induce an incomplete form of infarction (128).

In a study of 36 formalin-fixed brain specimens, lacunae accounted for most white matter abnormalities in elderly patients (21). Although MRI cannot distinguish noncystic infarction from either gliosis or demyelination, fluid-containing spaces, including cystic infarction and brain cysts, appear as isointense relative to CSF (22). The frontal lobes are more affected by subcortical small vessel ischemia. Regardless of location, white matter abnormalities are associated with hypometabolism of the frontal lobes and executive dysfunction (156).

Enlarged perivascular spaces may appear in the periventricular region and be confused with lacunar infarcts (84; 63). However, small perivascular spaces are found in all age groups, including newborns, suggesting they may not represent a true abnormality (154).

In addition to arterial stenosis, noninflammatory collagenous thickening of periventricular veins resulting in severe stenosis was found in 65% of brain autopsies in elderly patients (115).

Subcortical white matter abnormalities disrupt the short corticocortical fibers, whereas periventricular lesions disrupt the long association fibers connecting distant cortical areas (37). As a result, white matter abnormalities are more likely to disrupt the local neuronal networks, whereas periventricular lesions affect the cognitive functions requiring the coordination of multiple cortical areas (111; 176). Disruption of the prefrontal-subcortical loops leads to memory, executive, gait, and balance dysfunction (37; 68; 173; 167).

Genetics

Genetics may explain up to half the variation in white matter abnormalities between individuals (04). The genetic influence explains about two thirds of the variability in cognitive functioning; neurologic covariation in the presence of white matter abnormalities and cognition could be explained by genetic effect in more than 70% of cases (32).

A matched co-twin analysis of elderly monozygotic twins revealed that white matter abnormalities correlate with glucose level, high-density lipoprotein cholesterol, and systolic blood pressure. Additionally, white matter abnormalities were associated with impaired cognition and physical function (33).

Co-occurrence of cerebrovascular disease and ApoE ε4 subtype has a synergistic effect on brain atrophy and white matter abnormalities (43). Both dizygotic and monozygotic male twins may have a higher vulnerability of ApoE ε4 carriers to injury or impaired repair (31).

Through genome-wide association studies, the rs12204590 stroke risk allele (on chromosome 6p25, near FOXF2) was associated with an increased MRI-defined burden of white matter abnormalities in stroke-free adults. Young patients (aged 2 to 32 years) with segmental deletions of FOXF2 showed an extensive burden of white matter abnormalities (120).

Race

In the Multi‐Ethnic Study of Atherosclerosis, after adjustment for cardiovascular risk factors and socioeconomic status, white matter abnormalities were not associated with race and ethnicity (05).

Age

Aging is an independent risk factor for the development of white matter abnormalities (06; 58; 57; 105; 182; 24; 47).

Additional risk factors

Cardiovascular risk factors. Hypertension and cerebral hypoperfusion due to systolic and diastolic hypotension, orthostatic hypotension, and heart failure have been linked to white matter abnormalities (06; 132). History of stroke or myocardial infarction, factor VIIc activity, and fibrinogen level were also associated with white matter abnormalities (25; 47). Patients with atrial fibrillation have more numerous and larger periventricular white matter abnormalities (39). In asymptomatic patients, the risk of discovering a cardioembolic source with transthoracic and transesophageal echocardiography increases with age (100). Diabetic-associated white matter abnormalities are a risk factor for stroke (54).

Hypertension. Hypertension is commonly associated with white matter abnormalities in asymptomatic subjects and in patients with a history of cerebrovascular disease (06; 57; 17; 162). A family history of stroke or hypertension in first-degree relatives is significantly associated with white matter abnormalities (135). Moreover, well-controlled blood pressure prevents the formation of white matter abnormalities (46). In addition to lacunar infarcts, white matter abnormalities are strongly associated with intracerebral hemorrhage, also caused by hypertension (79).

White matter abnormalities (FLAIR MRI) (3)

FLAIR MRI of the brain identifies marked periventricular changes as well as extensive subcortical white matter changes in an elderly male. Hypertension was the patient’s sole vascular risk factor of this patient with clinical feat...
White matter abnormalities (T2-weighted MRI) (3)

This T2-weighted MRI identifies marked periventricular changes and subcortical white matter changes in the brain of an elderly male with hypertension as the sole vascular risk factor and with clinical features of mild cognitive im...

Although not demonstrated, the co-occurrence of cerebrovascular risk factors may be associated with an even higher white matter lesion load.

White matter abnormalities (FLAIR MRI) (4)

This FLAIR MRI identifies extensive periventricular and subcortical white matter changes in the brain of an elderly female with both poorly controlled hypertension and diabetes mellitus and with clinical features of dementia and p...
White matter abnormalities (FLAIR MRI) (5)

This FLAIR MRI demonstrates extensive cerebral white matter lesions in the brain of an elderly female with clinical features of dementia and poor executive function. (Contributed by Dr. Cory Toth.)

Diabetes mellitus. Elevated glycated hemoglobin levels and diabetes mellitus have been associated with white matter abnormalities (142; 47; 118).

White matter abnormalities (FLAIR MRI) (1)

This FLAIR MRI demonstrates white matter abnormalities over periventricular locations as well as over the right anteroinferior corona radiata in the brain of an elderly patient with diabetes and gait abnormality. (Contributed by D...
White matter abnormalities (T2-weighted MRI) (1)

This T2-weighted MRI identifies white matter changes over the more superior right corona radiate in the brain of an elderly patient with diabetes and gait abnormality. (Contributed by Dr. Cory Toth.)

Migraine. Migraineurs have a high incidence of white matter abnormalities, 46% in one study (149). These abnormalities occur mostly in young patients (126). White matter abnormalities are usually seen in the periventricular white matter or near grey-white matter junctional areas (136). The white matter abnormalities may be reversible, as was the case of a teenager with basilar migraine (106). No microstructural changes were detected on diffusion tensor imaging between episodic and chronic migraine (119).

White matter abnormalities (FLAIR MRI) (2)

This FLAIR MRI of the brain of a 30-year-old female migraineur shows presence of small white matter abnormalities without obvious clinical correlates. (Contributed by Dr. Cory Toth.)
White matter abnormalities (T2-weighted MRI) (2)

This T2-weighted MRI of the brain of a 30-year-old female migraineur shows presence of small white matter abnormalities resembling perivascular spaces and another larger white matter abnormality over the basal ganglia. (Contribute...

Dementia. Between 19% and 78% of patients with dementia have leukoaraiosis on CT scan (91; 14; 45; 103); and 7.5% to 100% on MRI (48; 18; 174; 108).

In Alzheimer disease, white matter abnormalities have been associated with advanced age, vascular risk factors, cerebral congophilic angiopathy, and homocysteine levels (81; 141; 78; 30). The members of an Irish family with familial Alzheimer disease due to an E280G mutation in exon 8 of presenilin-1 have developed spasticity along with white matter abnormalities (125).

White matter abnormalities may also occur in patients with Lewy body disease (09). Patients with vascular dementia have higher numbers of white matter abnormalities than those with either Lewy body disease or Alzheimer disease (09).

Apolipoprotein E ε4 status. Carriers of ApoE ε4 have significantly more subcortical white matter abnormalities than ApoE ε3 carriers, independent of hypertension. The combination of hypertension and at least one ApoE ε4 allele leads to the highest amounts for both subcortical and periventricular white matter abnormalities (40). Yet in another study controlling for confounding cerebrovascular risk factors, the number of ApoE ε4 alleles was not associated with white matter abnormalities, which were only found to be associated positively with age and hypertension (77).

AIDS dementia. Patients with AIDS dementia complex can have associated cerebral atrophy and white matter abnormalities in the splenium and deep subcortical areas (26).

Psychiatric disorders. Although any association remains uncertain due to methodological problems, psychiatric disorders that have been associated with an excessive burden of white matter abnormalities include depression in the elderly (36; 76), bipolar disease (153; 07), late-onset mania (107), and late-onset schizophrenia (23). A small study found white matter abnormalities in the right frontoparietal subcortical white matter in patients with bipolar disorder but not in the control group (67). A small study of patients with major depressive disorder has suggested the presence of a greater number of subcortical white matter abnormalities, particularly in patients with depressed folate levels or hypertension (80).

CADASIL. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy is characterized by multiple subcortical infarcts and white matter abnormalities with autosomal dominant inheritance related to a genetic defect on chromosome 19q12 (155). Patients with CADASIL also experience migraine, mood disturbances, and recurrent strokes, often with progression to subcortical dementia and premature death. White matter abnormalities are more likely to occur in the insula and temporal lobes in patients with CADASIL than in hypertensive patients. In addition, involvement of the external capsule and corpus callosum may be more specific for CADASIL patient brains (127). Pathologically, CADASIL is characterized by small, deep strokes and leukoencephalopathy. Small vessels in the brain have a concentric thickening of tunica media secondary to granular eosinophilic infiltration (10; 64).

As patients with CADASIL age, MRI signal abnormalities increase (34). Besides the subcortical and periventricular regions, the brainstem can also be subject to T2 signal hyperintensities, most frequently within the pons, in the brains of CADASIL patients.

CARASIL. Cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy (CARASIL), like CADASIL, is associated with multiple subcortical infarctions and due to a mutation in the HTRA1 gene, which prevents effective regulation of TGF-beta signaling and may lead to abnormal blood vessel formation in the brain. Symptoms typically begin in the patient’s thirties or forties and are characterized by leg spasticity and gait ataxia. About half of patients suffer from a stroke before 40 years of age. Dementia and memory loss typically occur within 20 years of onset. Scalp alopecia and attacks of low back pain are characteristic of the disease (74).

Susac syndrome. Susac syndrome is characterized by the triad of encephalopathy, retinopathy, and hearing loss. The recurrent flares result from a thrombotic microvasculopathy of unclear etiology (62; 181).

Trauma. Traumatic brain injury may result in white matter abnormalities associated with abnormal perfusion on SPECT scan 6 months after injury. Patients with abnormal perfusion to the frontal or temporal lobes had significantly worse outcomes 2 years after the event (168).

Electrical injury can result in brain atrophy, sometimes progressive, and supratentorial white matter abnormalities (112). Electrical injury may result in acute neurologic complications like amnesia, seizures, or coma as well as delayed complications such as choreoathetosis, cerebellar ataxia, and parkinsonism. MRI may demonstrate acute subcortical white matter abnormalities and basal ganglia lesions that may persist for several weeks, in addition to cerebellar and cerebral atrophy (85).

Metabolic disorders.

Wilson disease. Wilson disease (hepatolenticular degeneration) is an autosomal recessive disorder of copper metabolism. MRI has demonstrated abnormally increased T2 signal within the putamen and caudate, but also in the thalamus, dentate nuclei, midbrain, and subcortical white matter (130).

Hallervorden-Spatz disease. Hallervorden-Spatz disease is a progressive movement disorder with abnormal iron deposition in the globus pallidus, substantia nigra, and red nucleus. MRI may reveal decreased T2 signal in the lentiform nuclei and perilentiform white matter but increased T2 signal within the periventricular white matter (55).

Neuroacanthocytosis. Neuroacanthocytosis is an uncommon neurodegenerative disorder associated with movement disorders, dementia, and acanthocytosis (abnormal, spiculated, or star-shaped red blood cells). T2-weighted MRI may identify regions with increased signal within the white matter of the periventricular regions and within the corpus callosum (121).

Dystonia. Dystonia has not been associated with traditional MRI changes, but diffusion tensor imaging may be sensitive enough to detect subcortical white matter asymmetry in dystonia patients (15). Although the reason for this diffusion tensor imaging association is not clear, it may relate to activity-dependent microstructural changes in abnormally firing neuronal projection fibers, as patients receiving botulinum toxin for dystonia have at least partial and transient reversal of these diffusion tensor imaging changes (15).

Fragile X-associated tremor and ataxia syndrome (FXTAS). This is an adult-onset neurodegenerative disorder mainly seen in carriers, usually males, of premutation alleles (55-200 CGG repeats) of the fragile X mental retardation 1 (FMR1) gene. Clinically, FXTAS may present with progressive intention tremor and gait ataxia, and MRI demonstrates white matter abnormalities, particularly within cerebral and cerebellar locations (65). The neuropathological hallmark of FXTAS is an intranuclear inclusion found in neurons and astrocytes throughout the CNS (66).

Pediatric diseases.

Cerebral palsy. Children with cerebral palsy have frequent white matter abnormalities. Eighty-eight percent of children have abnormal findings on MRI, including frequent changes of white matter disease of immaturity. Although focal infarcts are identified in 7% of children with cerebral palsy, periventricular leukomalacia is identified in 43%, and lesions within the basal ganglia and cortical or subcortical regions are also commonly seen (11). Such changes were reported in 71% of children with diplegia and could also be found in patients with cerebral palsy, hemiplegia (34%), and quadriplegia (35%). The location of such white matter lesions in diplegic patients was posterior dominant, whereas patients with quadriplegia had evidence of diffuse white matter changes. Those patients with basal ganglia or thalamic changes tended to have a dystonic form of cerebral palsy (11).

Leukodystrophies. Several disorders with onset in childhood present with white matter disease on MRI. Although they resemble white matter abnormalities in adults, their nature is different. Additionally, the grey matter and peripheral nervous system may be affected. These genetic disorders, resulting in accumulation of abnormal metabolites, disrupt the myelin. The main leukodystrophies are adrenoleukodystrophy, Krabbe globoid cell, and metachromatic leukodystrophy.

Adrenoleukodystrophy. Adrenoleukodystrophy is a peroxisomal disorder resulting in the accumulation of very long-chain fatty acids. It is both a demyelinating and dysmyelinating disorder. Over time, the initial lesions of the parietal and occipital lobes progress towards the frontotemporal regions. In advanced disease, the internal capsule, corpus callosum, corticospinal tracts, and other white matter fiber tracts in the brainstem can be involved. The lesions tend to be contiguous within fiber tracts and confluent within the white matter regions. Typically, the white matter abnormalities are large and symmetric (93).

Krabbe disease. Krabbe disease (globoid cell leukodystrophy) is an autosomal recessive disorder that presents shortly after birth and progresses rapidly. The galactocerebroside beta-galactosidase deficiency leads to abnormal production and maintenance of myelin. MRI reveals bilateral, confluent white matter abnormalities within the cerebrum and cerebellum (44).

Metachromatic leukodystrophy. Metachromatic leukodystrophy is an autosomal recessive lysosomal disorder caused by a deficiency of arylsulfatase A. This is primarily a dysmyelinating disorder. The thalamus, posterior limb of the internal capsule, cerebellum, and quadrigeminal plate are most affected (89).

Other leukodystrophies include Alexander disease, Canavan disease, Pelizaeus-Merzbacher disease, Cockayne syndrome, Hurler disease, and Lowe syndrome.

Mitochondrial diseases. These disorders result in energy metabolism of mitochondria and may also present with evidence of white matter abnormalities.

Leigh disease. Leigh disease (subacute necrotizing encephalomyelopathy) is autosomal recessive, usually with onset in infancy or childhood. T2 MRI may reveal symmetric areas of increased signal within the basal ganglia, brainstem, and cerebellum (110).

Kearns-Sayre syndrome. Kearns-Sayre syndrome in children may appear as T2 hyperintensities of the basal ganglia and brainstem (158).

Mitochondrial encephalopathy with lactic acidosis and stroke-like episodes (MELAS). MELAS causes metabolic ischemia and infarcts within subcortical white matter that do not correspond to vascular territories (158).

Combined complex I and IV deficiency. Combined complex I and IV deficiency in children presents with extensive white matter abnormalities (158; 41).

Pyridoxine deficiency. Pyridoxine deficiency should be suspected in infants with epilepsy and frontal or occipital white matter lesions (82).

Cytomegalovirus. Cytomegalovirus infection can present with white matter abnormalities on MRI, including multifocal lesions within deep parietal white matter (160).

Myotonic dystrophy. Most patients with type 1 or 2 myotonic dystrophy exhibit white matter abnormalities or cerebral atrophy. In type 1, intellectual dysfunction is associated with white matter abnormalities in the anterior temporal lobe (92).

Prevention

	• Control of the cerebrovascular risk factors seems reasonable to prevent white matter abnormalities.
	• Intensive blood pressure control is more effective than standard blood pressure control at delaying an increase in white matter abnormality burden.
	• Angiotensin-converting enzyme inhibitors were associated with the best prevention of white matter abnormality progression.
	• Statin use may reduce the risk of dementia, but the effect on white matter abnormalities and intracerebral hemorrhage is unclear.
	• There is no evidence for using antiplatelet medication for white matter abnormality prevention.

As white matter abnormalities share the risk factors with cerebrovascular disease, it is reasonable to assume that prevention should involve control of vascular risk factors, such as diabetes, hyperlipidemia, or hypertension. However, the benefit of various measures should be weighed against the potential side effects.

Control of hypertension reduces the burden of white matter abnormalities (161). In an observational cohort analysis of the SPRINT-MIND trial (Systolic Blood Pressure Trial Memory and Cognition in Decreased Hypertension), which included 448 individuals, angiotensin-converting enzyme inhibitors were associated with the best prevention of white matter abnormality progression over a 4-year period. This effect was independent of blood pressure control or age (60). On the other hand, intensive blood pressure treatment (systolic blood pressure lower than 120 mm Hg), compared with standard therapy (systolic blood pressure lower than 140 mmHg), was associated with a slower increase of white matter abnormalities (133). The beneficial effects of blood pressure control should be balanced against the increased risk of brain volume loss, syncope, and renal dysfunction (150).

Administration of simvastatin in healthy, middle-aged adults resulted in preserved white matter microstructure and volume at 18 months (169). High-dose atorvastatin decreased the risk of stroke more in patients with internal carotid artery stenosis than in those with small vessel disease (147). Although statins were found to reduce the risk of dementia (83; 184), their use was associated with both prevention and progression of white matter abnormalities (69; 61). Of additional concern is the increased risk of intracerebral hemorrhage with intensive cholesterol reduction (137). However, statin use before intracerebral hemorrhage does not seem to adversely influence the outcome (96).

Antiplatelets are widely used to prevent ischemic stroke. However, there is no convincing evidence that antiplatelets prevent dementia in patients with white matter abnormalities, but there may be an increased risk for hemorrhagic complications (94).

Differential diagnosis

Confusing conditions

Enlarged perivascular spaces are areas surrounding the blood vessels filled with CSF. Lacunar stroke appears in T2 MRI as white matter hyperintensity surrounding a small cavity. However, in approximately 20% of patients with recent small subcortical strokes, the cavitation is not visible on MRI by 3 months (129).

Because fluid suppression may be affected by multiple factors, the FLAIR sequence may not be able to distinguish white matter abnormalities from lacunes or perivascular spaces as well as T1- and T2-weighted sequences (116). Moreover, approximately 50% of enlarged perivascular spaces are surrounded by FLAIR hyperintensity reflecting perivascular spaces, gliosis, or both (29).

Demyelinating lesions, such as those in multiple sclerosis and associated disorders such as Sjögren disease (117), form the most common differential diagnosis for white matter abnormalities. Although these disorders are often differentiated clinically, and some radiological features may help distinguish them, they cannot be readily differentiated (22).

Associated or underlying disorders

Multiple sclerosis. The classical definition of multiple sclerosis is the presence of two or more central nervous system lesions separated in time and space, not caused by other central nervous system diseases. White matter abnormalities in MS are traditionally referred to as plaques. Although some acute plaques will enhance with gadolinium, early plaques or inactive plaques can be hyperintense or even isointense on T2-weighted MRI (27). Most early active lesions appear hyperintense on T2-weighted MRI with a hypointense ring, possibly containing activated macrophages. Late active lesions that are hyperintense on T2-weighted images often appear hypointense on T1-weighted images, possibly related to axonal loss and demyelination. Some typical features for white matter abnormalities due to MS include the presence of multiple ovoid-shaped bright lesions on T2-weighted MRI; some infratentorial lesions, particularly in the cerebellar peduncles; lesions having an abrupt loss of T2 signal at the gray matter; lesions in a periventricular location; lesion size greater than 5 mm; and the presence of lesions in the corpus callosum (123).

White matter abnormalities (FLAIR MRI) (6)

This FLAIR MRI demonstrates a number of ovoid lesions over the corona radiata in the brain of a young female patient with clinically definite multiple sclerosis. Other lesions were identified over periventricular locations and inf...
White matter lesions in multiple sclerosis (T1-weighted MRI)

This is a T1-weighted MRI of the brain with gadolinium provision of a young female patient with clinically definite multiple sclerosis. Several lesions demonstrate gadolinium enhancement, most typical for active demyelinating d...

References

01: Alosco ML, Brickman AM, Spitznagel MB, et al. Cerebral perfusion is associated with white matter hyperintensities in older adults with heart failure. Congest Heart Fail 2013;19(4):E29-34. PMID 23517434
02: Alzheimer A. Die Seelenstörungen auf arteriosklerotischer Grundlage. Allg Z Psychiat 1902;59:695-701.
03: Artero S, Tiemeier H, Prins ND, Sabatier R, Breteler MM, Ritchie K. Neuroanatomical localisation and clinical correlates of white matter lesions in the elderly. J Neurol Neurosurg Psychiatry 2004;75(9):1304-8. PMID 15314121
04: Atwood LD, Wolf PA, Heard-Costa NL, et al. Genetic variation in white matter hyperintensity volume in the Framingham Study. Stroke 2004;35(7):1609-13. PMID 15143299
05: Austin TR, Nasrallah IM, Erus G, et al. Association of brain volumes and white matter injury with race, ethnicity, and cardiovascular risk factors: The Multi-Ethnic Study of Atherosclerosis. J Am Heart Assoc 2022;11(7):e023159. PMID 35352569
06: Awad IA, Spetzler RF, Hodak JA, Awad CA, Carey R. Incidental subcortical lesions identified on magnetic resonance imaging in the elderly, I: correlation with age and cerebrovascular risk factors. Stroke 1986;17:1084-9. PMID 3810705
07: Aylward EH, Roberts-Twillie JV, Barta PE, et al. Basal ganglia volumes and white matter hyperintensities in patients with bipolar disorder. Am J Psychiatry 1994;151:687-93. PMID 8166310
08: Bae CJ, Pincus JH. Neurologic signs predict periventricular white matter lesions on MRI. Can J Neurol Sci 2004;31(2):242-7. PMID 15198451
09: Barber R, Scheltens P, Gholkar A, et al. White matter lesions on magnetic resonance imaging in dementia with Lewy bodies, Alzheimer's disease, vascular dementia, and normal aging. J Neurol Neurosurg Psychiatry 1999;67(1):66-72. PMID 10369824
10: Baudrimont M, Dubas F, Joutel A, Tournier-Lasserve E, Bousser MG. Autosomal dominant leukoencephalopathy and subcortical ischemic stroke: a clinicopathological study. Stroke 1993;24:122-5. PMID 8418535
11: Bax M, Tydeman C, Flodmark O. Clinical and MRI correlates of cerebral palsy: the European Cerebral Palsy Study. JAMA 2006;296(13):1602-8. PMID 17018805
12: Binswanger O. Die Abgrenzung der allgemeinen progressiven Paralyse. Berl Klin Wochenschr 1894;31:1102-86.
13: Blass JP, Hoyer S, Nitsch R. A translation of Otto Binswanger's article, 'The delineation of the generalized progressive paralyses'. 1894. Arch Neurol 1991;48:961-72. PMID 1953422
14: Blennow K, Wallin A, Uhlemann C, Gottfries CG. White-matter lesions on CT in Alzheimer patients: relation to clinical symptomatology and vascular factors. Acta Neurol Scand 1991;83:187-93. PMID 2031453
15: Blood AJ, Tuch DS, Makris N, Makhlouf ML, Sudarsky LR, Sharma N. White matter abnormalities in dystonia normalize after botulinum toxin treatment. Neuroreport 2006;17(12):1251-5. PMID 16951564
16: Bocti C, Swartz RH, Gao FQ, Sahlas DJ, Behl P, Black SE. A new visual rating scale to assess strategic white matter hyperintensities within cholinergic pathways in dementia. Stroke 2005;36(10):2126-31. PMID 16179569
17: Bogousslavsky J, Regli F, Uske A. Leukoencephalopathy in patients with ischemic stroke. Stroke 1987;18:896-9. PMID 3629648
18: Bondareff W, Raval J, Colletti PM, Hauser DL. Quantitative magnetic resonance imaging and the severity of dementia in Alzheimer's disease. Am J Psychiatry 1988;145:853-6. PMID 3381931
19: Boone KB, Miller BL, Lesser IM, et al. Neuropsychological correlates of white-matter lesions in healthy elderly subjects: a threshold effect. Arch Neurol 1992;49:549-54. PMID 1580819
20: Bradley WG Jr, Waluch V, Brandt-Zawadzki M, Yadley RA, Wycoff RR. Patchy, periventricular white matter lesions in the elderly: a common observation during NMR imaging. Noninv Med Imag 1984;1:35-41.
21: Braffman BH, Zimmerman RA, Trojanowski JQ, Gonatas NK, Hickey WF, Schlaepfer WW. Brain MR: pathologic correlation with gross and histopathology. 1. Lacunar infarction and Virchow-Robin spaces. Am J Roentgenol 1988a;151(3):551-8. PMID 3261517
22: Braffman BH, Zimmerman RA, Trojanowski JQ, Gonatas NK, Hickey WF, Schlaepfer WW. Brain MR: pathologic correlation with gross and histopathology. 2. Hyperintense white-matter foci in the elderly. AJR Am J Roentgenol 1988b;151(3):559-66. PMID 3261518
23: Breitner JC, Husain MM, Figiel GS, Krishnan KRR, Boyko OB. Cerebral white matter disease in late-onset paranoid psychosis. Biol Psychiatry 1990;28:266-74. PMID 2378929
24: Breteler MM, van Amerongen NM, van Swieten JC, et al. Cognitive correlates of ventricular enlargement and cerebral white matter lesions on magnetic resonance imaging: the Rotterdam Study. Stroke 1994b;25:1109-15. PMID 8202966
25: Breteler MM, van Swieten JC, Bots ML, et al. Cerebral white matter lesions, vascular risk factors, and cognitive function in a population-based study: the Rotterdam Study. Neurology 1994a;44:1246-52. PMID 8035924
26: Broderick DF, Wippold FJ 2nd, Clifford DB, Kido D, Wilson BS. White matter lesions and cerebral atrophy on MR images in patients with and without AIDS dementia complex. AJR Am J Roentgenol 1993;161(1):177-81. PMID 8517298
27: Bruck W, Bitsch A, Kolenda H, Bruck Y, Stiefel M, Lassmann H. Inflammatory central nervous system demyelination: correlations of magnetic resonance imaging findings with lesion pathology. Ann Neurol 1997;42:783-93. PMID 9392578
28: Burns JM, Church JA, Johnson DK, et al. White matter lesions are prevalent but differentially related with cognition in aging and early Alzheimer disease. Arch Neurol 2005;62(12):1870-6. PMID 16344345
29: Cannistraro RJ, Badi M, Eidelman BH, et al. CNS small vessel disease: a clinical review. Neurology 2019;92(24):1146-56. PMID 31142635
30: Capizzano AA, Acion L, Bekinschtein T, et al. White matter hyperintensities are significantly associated with cortical atrophy in Alzheimer's disease. J Neurol Neurosurg Psychiatry 2004;75(6):822-7. PMID 15145992
31: Carmelli D, DeCarli C, Swan GE, et al. The joint effect of apolipoprotein E epsilon4 and MRI findings on lower-extremity function and decline in cognitive function. J Gerontol A Biol Sci Med Sci 2000;55(2):M103-9. PMID 10737693
32: Carmelli D, Reed T, DeCarli C. A bivariate genetic analysis of cerebral white matter hyperintensities and cognitive performance in elderly male twins. Neurobiol Aging 2002;23(3):413-20. PMID 11959404
33: Carmelli D, Swan GE, Reed T, Wolf PA, Miller BL, DeCarli C. Midlife cardiovascular risk factors and brain morphology in identical older male twins. Neurology 1999;52(6):1119-24. PMID 10214731
34: Chabriat H, Mrissa R, Levy C, et al. Brain stem MRI signal abnormalities in CADASIL. Stroke 1999;30(2):457-9. PMID 9933287
35: Chimowitz MI, Estes ML, Furlan AJ, Awad IA. Further observations on the pathology of subcortical lesions identified on magnetic resonance imaging. Arch Neurol 1992;49:747-52. PMID 1497503
36: Coffey CE, Figiel GS, Djang WT, Weiner RD. Subcortical hyperintensity on magnetic resonance imaging: a comparison of normal and depressed elderly subjects. Am J Psychiatry 1990;147:187-9. PMID 2301657
37: de Groot JC, de Leeuw FE, Oudkerk M, et al. Cerebral white matter lesions and cognitive function: The Rotterdam Scan Study. Ann Neurol 2000;47:145-51. PMID 10665484
38: De Leeuw FE, de Groot JC, Achten E, et al. Prevalence of cerebral white matter lesions in elderly people: a population based magnetic resonance imaging study. The Rotterdam Scan Study. J Neurol Neurosurg Psychiatry 2001;70(1):9-14. PMID 11118240
39: De Leeuw FE, de Groot JC, Oudkerk M, et al. Atrial fibrillation and the risk of cerebral white matter lesions. Neurology 2000;54(9):1795-801. PMID 10802786
40: De Leeuw FE, Richard F, de Groot JC, et al. Interaction between hypertension, ApoE, and cerebral white matter lesions. Stroke 2004b;35(5):1057-60. PMID 15060316
41: de Lonlay-Debeney P, von Kleist-Retzow JC, Hertz-Pannier L, et al. Cerebral white matter disease in children may be caused by mitochondrial respiratory chain deficiency. J Pediatr 2000;136(2):209-14. PMID 10657827
42: Deary IJ, Leaper SA, Murray AD, Staff RT, Whalley LJ. Cerebral white matter abnormalities and lifetime cognitive change: a 67-year follow-up of the Scottish Mental Survey of 1932. Psychol Aging 2003;18(1):140-8. PMID 12641318
43: DeCarli C, Reed T, Miller BL, Wolf PA, Swan GE, Carmelli D. Impact of apolipoprotein E epsilon4 and vascular disease on brain morphology in men from the NHLBI twin study. Stroke 1999;30(8):1548-53. PMID 10436099
44: Demaerel P, Wilms G, Verdru P, et al. MR findings in globoid cell leukodystrophy. Neuroradiol 1990;32:520-2. PMID 2287386
45: Diaz JF, Merskey H, Hachinski VC, et al. Improved recognition of leukoaraiosis and cognitive impairment in Alzheimer's disease. Arch Neurol 1991;48:1022-5. PMID 1929892
46: Dufouil C, de Kersaint-Gilly A, Besancon V, et al. Longitudinal study of blood pressure and white matter hyperintensities: the EVA MRI Cohort. Neurology 2001;56(7):921-6. PMID 11294930
47: Erkinjuntti T, Gao F, Lee DH, Eliasziw M, Merskey H, Hachinski VC. Lack of difference in brain hyperintensities between patients with early Alzheimer's disease and control subjects. Arch Neurol 1994;51:260-8. PMID 8129637
48: Erkinjuntti T, Ketonen L, Sulkava R, Sipponen J, Vuorialho M, Iivanainen M. Do white matter changes on MRI and CT differentiate vascular dementia from Alzheimer's disease. J Neurol Neurosurg Psychiatry 1987;50:37-42. PMID 3819754
49: Erkinjuntti T, Roman G, Gauthier S. Treatment of vascular dementia--evidence from clinical trials with cholinesterase inhibitors. J Neurol Sci 2004;226(1-2):63-6. PMID 15537522
50: Fazekas F, Alavi A, Chawluk JB, et al. Comparison of CT, MR, and PET in Alzheimer's dementia and normal aging. J Nucl Med 1989;30:1607-15. PMID 2795200
51: Fazekas F, Kleinert R, Offenbacher H, et al. The morphologic correlate of incidental punctate white matter hyperintensities on MR images. AJNR Am J Neuroradiol 1991;12:915-21. PMID 1950921
52: Fazekas F, Kleinert R, Offenbacher H, et al. Pathologic correlates of incidental MRI white matter signal hyperintensities. Neurology 1993;43:1683-9. PMID 8414012
53: Fazekas F, Schmidt R, Scheltens P. Pathophysiologic mechanisms in the development of age-related white matter changes of the brain. Dement Geriatr Cogn Disord 1998;9(Suppl 1):2-5. PMID 9716237
54: Fushimi H, Inoue T, Yamada Y, Udaka F, Kameyama M. Asymptomatic cerebral small infarcts (lacunae), their risk factors and intellectual disturbances. Diabetes 1996;45(Suppl 3):S98-100. PMID 8674905
55: Gallucci M, Cardona F, Arachi M, et al. Follow-up MR studies in Hallervorden-Spatz disease. J Comput Assist Tomogr 1990;14:118. PMID 2298974
56: Garde E, Mortensen EL, Krabbe K, Rostrup E, Larsson HB. Relation between age-related decline in intelligence and cerebral white-matter hyperintensities in healthy octogenarians: a longitudinal study. Lancet 2000;356:628-34. PMID 10968435
57: George AE, de Leon MJ, Gentes CI, et al. Leukoencephalopathy in normal and pathologic aging, I: CT of brain lucencies. AJNR Am J Neuroradiol 1986b;7:561-6. PMID 3088933
58: George AE, de Leon MJ, Kalnin A, Rosner L, Goodgold A, Chase N. Leukoencephalopathy in normal and pathologic aging, II: MRI of brain lucencies. AJNR Am J Neuroradiol 1986a;7:567-70. PMID 3088934
59: Gerard G, Weisberg LA. MRI periventricular lesions in adults. Neurology 1986;36:998-1001. PMID 3714061
60: Goldstein ED, Wolcott Z, Garg G, et al. Effect of antihypertensives by class on cerebral small vessel disease: a post hoc analysis of SPRINT-MIND. Stroke 2022;53(8):2435-40. PMID 35506388
61: Goldstein ED, Garg G, Navarro K, et al. Statin usage increases white matter hyperintensities: a post hoc analysis of SPRINT-MIND. Neurologist 2023;28(2):94-8. PMID 35680399
62: Gordon DL, Hayreh SS, Adams HP. Microangiopathy of the brain, retina, and ear: improvement without immunosuppressive therapy. Stroke 1991;22:933-7. PMID 1853414
63: Grafton ST, Sumi SM, Stimac GK, Alvord EC Jr, Shaw CM, Nochlin D. Comparison of postmortem magnetic resonance imaging and neuropathologic findings in the cerebral white matter. Arch Neurol 1991;48:293-8. PMID 1705796
64: Gray F, Robert F, Labrecque R, et al. Autosomal dominant arteriopathic leuko-encephalopathy and Alzheimer's disease. Neuropathol Appl Neurobiol 1994;20:22-30. PMID 8208337
65: Greco CM, Berman RF, Martin RM, et al. Neuropathology of fragile X-associated tremor/ataxia syndrome (FXTAS). Brain 2006;129(Pt 1):243-55. PMID 16332642
66: Greco CM, Hagerman RJ, Tassone F, et al. Neuronal intranuclear inclusions in a new cerebellar tremor/ataxia syndrome among fragile X carriers. Brain 2002;125(Pt 8):1760-71. PMID 12135967
67: Gulseren S, Gurcan M, Gulseren L, Gelal F, Erol A. T(2) Hyperintensities in Bipolar Patients and their Healthy Siblings. Arch Med Res 2006;37(1):79-85. PMID 16314191
68: Gunning-Dixon FM, Raz N. The cognitive correlates of white matter abnormalities in normal aging: a quantitative review. Neuropsychology 2000;14:224-32. PMID 10791862
69: Guo Y, Li Y, Liu X, et al. Assessing the effectiveness of statin therapy for alleviating cerebral small vessel disease progression in people ≥75 years of age. BMC Geriatr 2020;20(1):292. PMID 32807086
70: Gupta SR, Naheedy MH, Young JC, Ghobrial M, Rubino FA, Hindo W. Periventricular white matter changes and dementia: clinical, neuropsychological, radiological, and pathological correlation. Arch Neurol 1988;45:637-41. PMID 3259421
71: Guttmann CR, Benson R, Warfield SK, et al. White matter abnormalities in mobility-impaired older persons. Neurology 2000;54(6):1277-83. PMID 10746598
72: Hachinski VC, Potter P, Merskey H. Leuko-araiosis: an ancient term for a new problem. Can J Neurol Sci 1986;13:533-4. PMID 3791068
73: Hachinski VC, Potter P, Merskey H. Leuko-araiosis. Arch Neurol 1987;44:21-3. PMID 3800716
74: Hara K, Shiga A, Fukutake T, et al. Association of HTRA1 mutations and familial ischemic cerebral small-vessel disease. N Engl J Med 2009;360(17):1729-39. PMID 19387015
75: Harrell LE, Duvall E, Folks DG, et al. The relationship of high-intensity signals on magnetic resonance images to cognitive and psychiatric state in Alzheimer's disease. Arch Neurol 1991;48:1136-40. PMID 1953397
76: Hickie I, Scott E, Mitchell P, Wilhelm K, Austin M-P, Bennett B. Subcortical hyperintensities on magnetic resonance imaging: clinical correlates and prognostic significance in patients with severe depression. Biol Psychiatry 1995;37:151-60. PMID 7727623
77: Hirono N, Yasuda M, Tanimukai S, Kitagaki H, Mori E. Effect of the apolipoprotein E epsilon4 allele on white matter hyperintensities in dementia. Stroke 2000b;31(6):1263-8. PMID 10835442
78: Hogervorst E, Ribeiro HM, Molyneux A, Budge M, Smith AD. Plasma homocysteine levels, cerebrovascular risk factors, and cerebral white matter changes (leukoaraiosis) in patients with Alzheimer disease. Arch Neurol 2002;59(5):787-93. PMID 12020261
79: Inzitari D, Mascalchi M. Leuko-araiosis: a reappraisal, I: CT studies. Ital J Neurol Sci 1990;11:241-8. PMID 2201663
80: Iosifescu DV, Papakostas GI, Lyoo IK, et al. Brain MRI white matter hyperintensities and one-carbon cycle metabolism in non-geriatric outpatients with major depressive disorder (Part I). Psychiatry Res 2005;140(3):291-9. PMID 16298109
81: Janota I, Mirsen TR, Hachinski VC, Lee DH, Merskey H. Neuropathological correlates of leuko-araiosis. Arch Neurol 1989;46:1124-8. PMID 2803072
82: Jardim LB, Pires RF, Martins CE, et al. Pyridoxine-dependent seizures associated with white matter abnormalities. Neuropediatrics 1994;25(5):259-61. PMID 7885536
83: Jick H, Zornberg GL, Jick SS, Seshadri S, Drachman DA. Statins and the risk of dementia. Lancet 2000;356(9242):1627-31. PMID 11089820
84: Jungreis CA, Kanal E, Hirsch WL, Martinez AJ, Moossy J. Normal perivascular spaces mimicking lacunar infarction: MR imaging. Radiology 1988;169:101-4. PMID 3420242
85: Kalita J, Jose M, Misra UK. Myelopathy and amnesia following accidental electrical injury. Spinal Cord 2002;40(5):253-5. PMID 11987009
86: Kerber KA, Enrietto JA, Jacobson KM, Baloh RW. Disequilibrium in older people: a prospective study. Neurology 1998;51(2):574-80. PMID 9710038
87: Kerber KA, Whitman GT, Brown DL, Baloh RW. Increased risk of death in community-dwelling older people with white matter hyperintensities on MRI. J Neurol Sci 2006;250(1-2):33-8. PMID 16889799
88: Kertesz A, Polk M, Carr T. Cognition and white matter changes on magnetic resonance imaging in dementia. Arch Neurol 1990;47:387-91. PMID 2322131
89: Kim TS, Kim IO, Kim WS, et al. MR of childhood metachromatic leukodystrophy. AJNR Am J Neuroradiol 1997;18(4):733-8. PMID 9127040
90: Kitagaki H, Mori E, Hirono N, et al. Alteration of white matter MR signal intensity in frontotemporal dementia. American Journal of Neuroradiology 1997;18:367-78. PMID 9111678
91: Kobari M, Meyer JS, Ichijo M. Leuko-araiosis, cerebral atrophy, and cerebral perfusion in normal aging. Arch Neurol 1990;47:161-5. PMID 2302088
92: Kornblum C, Reul J, Kress W, et al. Cranial magnetic resonance imaging in genetically proven myotonic dystrophy type 1 and 2. J Neurol 2004;251(6):710-4. PMID 15311347
93: Kumar AJ, Rosenbaum AE, Naidu S, et al. Adrenoleukodystrophy: correlating MR imaging with CT. Radiology 1987;165:497-504. PMID 3659373
94: Kwan J, Hafdi M, Chiang LL, et al. Antithrombotic therapy to prevent cognitive decline in people with small vessel disease on neuroimaging but without dementia. Cochrane Database Syst Rev 2022;7(7):CD012269. PMID 35833913
95: Lasbury N, Garg B, Edwards-Brown M, Cowan LD, Dimassi H, Bodensteiner JB. Clinical correlates of white-matter abnormalities on head magnetic resonance imaging. J Child Neurol 2001;16(9):668-72. PMID 11575608
96: Lei C, Wu B, Liu M, Chen Y. Association between statin use and intracerebral hemorrhage: a systematic review and meta-analysis. Eur J Neurol 2014;21(2):192-8. PMID 24118228
97: Leifer D, Buonanno FS, Richardson EP Jr. Clinicopathologic correlations of cranial magnetic resonance imaging of periventricular white matter. Neurology 1990;40:911-8. PMID 2345614
98: Liao D, Cooper L, Cai J, et al. The prevalence and severity of white matter lesions, their relationship with age, ethnicity, gender, and cardiovascular disease risk factors: The ARIC study. Neuroepidemiology 1997;16:149-62. PMID 9159770
99: Lin MP, Brott TG, Liebeskind DS, et al. Collateral recruitment is impaired by cerebral small vessel disease. Stroke 2020;51(5):1404-10. PMID 32248770
100: Lindgren A, Roijer A, Rudling O, et al. Cerebral lesions on magnetic resonance imaging, heart disease, and vascular risk factors in subjects without stroke. Stroke 1994;25:929-34. PMID 8165686
101: Liu CK, Miller BL, Cummings JL, et al. A quantitative MRI study of vascular dementia. Neurology 1992;42:138-43. PMID 1734295
102: London E, de Leon MJ, George AE, et al. Periventricular lucencies in the CT scans of aged and demented patients. Biol Psychiatry 1986;21:960-2. PMID 3741912
103: Lopez OL, Becker JT, Rezek D, et al. Neuropsychiatric correlates of cerebral white-matter radiolucencies in probable Alzheimer's disease. Arch Neurol 1992;49:828-34. PMID 1524516
104: Lotz PR, Ballinger WE Jr, Quisling RG. Subcortical arteriosclerotic encephalopathy: CT spectrum and pathologic correlation. AJNR Am J Neuroradiol 1986;147(6):1209-14. PMID 3490756
105: Matsubayashi K, Shimada K, Kawamoto A, Ozaka T. Incidental brain lesions on magnetic resonance imaging and neurobehavioral functions in the apparently healthy elderly. Stroke 1992;23:175-80. PMID 1561644
106: Maytal J, Libman RB, Lustrin ES. Basilar artery migraine and reversible imaging abnormalities. AJNR Am J Neuroradiol 1998;19(6):1116-9. PMID 9672022
107: McDonald WM, Krishnan KR, Doraiswamy PM, Blazer DG. Occurrence of subcortical hyperintensities in elderly subjects with mania. Psychiatry Res Neuroimaging 1991b;40:211-20. PMID 1811239
108: McDonald WM, Krishnan KR, Doraiswamy PM, et al. Magnetic resonance findings in patients with early-onset Alzheimer's disease. Biol Psychiatry 1991a;29:799-810. PMID 2054453
109: McGuinness B, Craig D, Bullock R, Malouf R, Passmore P. Statins for the treatment of dementia. Cochrane Database Syst Rev 2014;(7):CD007514. PMID 25004278
110: Medina L, Chi TL, DeVivo DC, et al. MR findings in patients with subacute necrotizing encephalomyelopathy (Leigh syndrome): correlation with biochemical defect. AJNR 1990;11:379. PMID 2156413
111: Mesulam MM. Large-scale neurocognitive networks and distributed processing for attention, language, and memory. Ann Neurol 1990;28(5):597-613. PMID 2260847
112: Milton WJ, Hal O'Dell R, Warner EG. MRI of lightning injury: early white matter changes associated with cerebral dysfunction. J Okla State Med Assoc 1996;89(3):93-4. PMID 8919853
113: Mistry EA, Mistry AM, Mehta T et al. White matter disease and outcomes of mechanical thrombectomy for acute ischemic stroke. AJNR Am J Neuroradiol 2020;41(4):639-44. PMID 32165366
114: Miyao S, Takano A, Teramoto J, Takahashi A. Leukoaraiosis in relation to prognosis for patients with lacunar infarction. Stroke 1992;23:1434-8. PMID 1412580
115: Moody DM, Brown WR, Challa VR, Anderson RL. Periventricular venous collagenosis: association with leukoaraiosis. Radiology 1995;194:469-76. PMID 7824728
116: Moreau F, Patel S, Lauzon ML, et al. Cavitation after acute symptomatic lacunar stroke depends on time, location, and MRI sequence. Stroke 2012;43(7):1837-42. PMID 22733793
117: Morgen K, McFarland HF, Pillemer SR. Central nervous system disease in primary Sjogrens syndrome: the role of magnetic resonance imaging. Semin Arthritis Rheum 2004;34(3):623-30. PMID 15609267
118: Murray AD, Staff RT, Shenkin SD, Deary IJ, Starr JM, Whalley LJ. Brain white matter hyperintensities: relative importance of vascular risk factors in nondemented elderly people. Radiology 2005;237(1):251-7. PMID 16126931
119: Neeb L, Bastian K, Villringer K, et al. No microstructural white matter alterations in chronic and episodic migraineurs: a case-control diffusion tensor magnetic resonance imaging study. Headache 2015;55(2):241-51. PMID 25644380
120: Neurology Working Group of the CHARGE Consortium; Stroke Genetics Network (SiGN); International Stroke Genetics Consortium (ISGC). Identification of additional risk loci for stroke and small vessel disease: a meta-analysis of genome-wide association studies. Lancet Neurol. 2016 Jun;15(7):695-707. PMID 27068588
121: Nicholl DJ, Sutton I, Dotti MT, Supple SG, Danek A, Lawden M. White matter abnormalities on MRI in neuroacanthocytosis. J Neurol Neurosurg Psychiatry 2004;75(8):1200-1. PMID 15258233
122: O'Brien JT, Firbank MJ, Krishnan MS, et al. White matter hyperintensities rather than lacunar infarcts are associated with depressive symptoms in older people: the LADIS study. Am J Geriatr Psychiatry 2006;14(10):834-41. PMID 17001023
123: Offenbacher H, Fazekas F, Schmidt R, et al. Assessment of MRI criteria for a diagnosis of MS. Neurology 1993;43:905-9. PMID 8274173
124: Olszewski J. Subcortical arteriosclerotic encephalopathy. World Neurol 1962;3:359-75. PMID 14481961
125: O'Riordan S, McMonagle P, Janssen JC, et al. Presenilin-1 mutation (E280G), spastic paraparesis, and cranial MRI white-matter abnormalities. Neurology 2002;59(7):1108-10. PMID 12370477
126: Osborn RE, Alder DC, Mitchell CS. MR imaging of the brain in patients with migraine headaches. AJNR 1991;12:521-4. PMID 2058506
127: O'Sullivan M, Jarosz JM, Martin RJ, Deasy N, Powell JF, Markus HS. MRI hyperintensities of the temporal lobe and external capsule in patients with CADASIL. Neurology 2001;56(5):628-34. PMID 11245715
128: Pantoni L, Garcia JH. Pathogenesis of leukoaraiosis: a review. Stroke 1997;28:652-9. PMID 9056627
129: Pinter D, Gattringer T, Enzinger C, et al. Longitudinal MRI dynamics of recent small subcortical infarcts and possible predictors. J Cereb Blood Flow Metab 2019;39(9):1669-77. PMID 29737904
130: Prayer L, Wimberger D, Kramer J, Grimm G, Oder W, Imhof H. Cranial MRI in Wilson's disease. Neuroradiol 1990;32:211-4. PMID 2215906
131: Prins ND, van Dijk EJ, den Heijer T, et al. Cerebral white matter lesions and the risk of dementia. Arch Neurol 2004;61(10):1531-4. PMID 15477506
132: Raiha I, Tarvonen S, Kurki T, Rajala T, Sourander L. Relationship between vascular factors and white matter low attenuation of the brain. Acta Neurol Scand 1993;87:286-9. PMID 8503257
133: Rashid T, Li K, Toledo JB, et al. Association of intensive vs standard blood pressure control with regional changes in cerebral small vessel disease biomarkers: post hoc secondary analysis of the SPRINT MIND Randomized Clinical Trial. JAMA Netw Open 2023;6(3):e231055. PMID 36857053
134: Rasmussen MK, Mestre H, Nedergaard M. Fluid transport in the brain. Physiol Rev 2022;102(2):1025-151. PMID 33949874
135: Reed T, Kirkwood SC, DeCarli C, et al. Relationship of family history scores for stroke and hypertension to quantitative measures of white-matter hyperintensities and stroke volume in elderly males. Neuroepidemiology 2000;19(2):76-86. PMID 10686532
136: Robbins L, Friedman H. MRI in migraineurs. Headache 1992;32(10):507-8. PMID 1468910
137: Romero JR, Preis SR, Beiser A, et al. Risk factors, stroke prevention treatments, and prevalence of cerebral microbleeds in the Framingham Heart Study. Stroke 2014;45(5):1492-4. PMID 24713533
138: Rosano C, Brach J, Longstreth Jr WT, Newman AB. Quantitative measures of gait characteristics indicate prevalence of underlying subclinical structural brain abnormalities in high-functioning older adults. Neuroepidemiology 2006;26(1):52-60. PMID 16254454
139: Rosano C, Kuller LH, Chung H, Arnold AM, Longstreth WT Jr, Newman AB. Subclinical brain magnetic resonance imaging abnormalities predict physical functional decline in high-functioning older adults.J Am Geriatr Soc 2005;53(4):649-54. PMID 15817012
140: Rosenberg GA, Kornfeld M, Stovring J, Bicknell JM. Subcortical arteriosclerotic encephalopathy (Binswanger): computerized tomography. Neurology 1979;29(8):1102-6. PMID 572497
141: Scheltens P, Barkhof F, Valk J, et al. White matter lesions on magnetic resonance imaging in clinically diagnosed Alzheimer's disease. Evidence for heterogeneity. Brain 1992;115(Pt 3):735-48. PMID 1628199
142: Schmidt R. Comparison of magnetic resonance imaging in Alzheimer's disease, vascular dementia and normal aging. Eur Neurol 1992;32:164-9. PMID 1592074
143: Schmidt R, Fazekas F, Kleinert G, et al. Magnetic resonance imaging signal hyperintensities in the deep and subcortical white matter: a comparative study between stroke patients and normal volunteers. Arch Neurol 1992;49:825-7. PMID 1524515
144: Schmidt R, Fazekas F, Offenbacher H, et al. Neuropsychological correlates of MRI white matter hyperintensities: a study of 150 normal volunteers. Neurology 1993;43:2490-4. PMID 8255445
145: Schneider R, Wieczorek V. Otto Binswanger (1852-1929). J Neurol Sci 1991;103:61-4. PMID 1865234
146: Schorer CE. Alzheimer and Kraeplin describe Binswanger's disease. J Neuropsychiatry Clin Neurosci 1992;4:55-8. PMID 1627963
147: Sillesen H, Amarenco P, Hennerici MG, et al. Atorvastatin reduces the risk of cardiovascular events in patients with carotid atherosclerosis: a secondary analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial. Stroke 2008;39(12):3297-302. PMID 18845807
148: Sliz E, Shin J, Ahmad S, et al. Circulating metabolome and white matter hyperintensities in women and men. Circulation 2022;145(14):1040-52. PMID 35050683
149: Soges LJ, Cacayorin ED, Petro GR, et al. Migraine: evaluation by MR. AJNR 1988;9:425-9. PMID 3132817
150: SPRINT Research Group. A randomized trial of intensive versus standard blood-pressure control. N Engl J Med 2015;373(22):2103-16. PMID 26551272
151: Starkstein SE, Sabe L, Vazquez S, et al. Neuropsychological, psychiatric, and cerebral perfusion correlates of leukoaraiosis in Alzheimer’s disease. J Neurol Neurosurg Psychiatry 1997;63:66-73. PMID 9221970
152: Steingart A, Hachinski VC, Lau C, et al. Cognitive and neurologic findings in subjects with diffuse white matter lucencies on computed tomographic scan (leuko-araiosis). Arch Neurol 1987;44:32-5. PMID 3800719
153: Swayze VW 2nd, Andreasen NC, Alliger RJ, Ehrhardt JC, Yuh WT. Structural brain abnormalities in bipolar affective disorder. Arch Gen Psychiatry 1990;47:1054-9. PMID 2241506
154: Sze G, De Armond SJ, Brant-Zawadzki M, Davis RL, Norman D, Newton TH. Foci of MRI signal (pseudolesions) anterior to the frontal horns: histologic correlations of a normal finding. AJNR Am J Neuroradiol 1986;7:381-7. PMID 3487952
155: Tournier-Lasserve E, Joutel A, Melki J, et al. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy maps on chromosome 19q12. Nat Genet 1993;3:256-9. PMID 8485581
156: Tullberg M, Fletcher E, DeCarli C, et al. White matter lesions impair frontal lobe function regardless of their location. Neurology 2004;63(2):246-53. PMID 15277616
157: Tupler LA, Coffey CE, Logue PE, Djang WT, Fagan SM. Neuropsychological importance of subcortical white matter hyperintensity. Arch Neurol 1992;49:1248-52. PMID 1449403
158: Valanne L, Ketonen L, Majander A, Suomalainen A, Pihko H. Neuroradiologic findings in children with mitochondrial disorders. AJNR Am J Neuroradiol 1998;19(2):369-77. PMID 9504497
159: van der Flier WM, van Straaten EC, Barkhof F, et al. Medial temporal lobe atrophy and white matter hyperintensities are associated with mild cognitive deficits in non-disabled elderly people: the LADIS study. J Neurol Neurosurg Psychiatry 2005;76(11):1497-500. PMID 16227537
160: van der Knaap MS, Vermeulen G, Barkhof F, Hart AA, Loeber JG, Weel JF. Pattern of white matter abnormalities at MR imaging: use of polymerase chain reaction testing of Guthrie cards to link pattern with congenital cytomegalovirus infection. Radiology 2004;230(2):529-36. PMID 14752192
161: van Middelaar T, Argillander TE, Schreuder FH, et al. Effect of antihypertensive medication on cerebral small vessel disease: a systematic review and meta-analysis. Stroke 2018;49(6):1531-3. PMID 29739911
162: van Swieten JC, Kappelle LJ, Algra A, et al. Hypodensity of the cerebral white matter in patients with transient ischemic attack or minor stroke: influence on the rate of subsequent stroke. Ann Neurol 1992;32:177-83. PMID 1510358
163: van Swieten JC, van Den Hout JH, van Ketel BA, Hijdra A, Wokke JH, van Gijn J. Periventricular lesions in the white matter on magnetic resonance imaging in the elderly: a morphometric correlation with arteriolosclerosis and dilated perivascular spaces. Brain 1991;114:761-74. PMID 2043948
164: Vasquez BP, Zakzanis KK. The neuropsychological profile of vascular cognitive impairment not demented: a meta-analysis. J Neuropsychol 2015;9(1):109-36. PMID 24612847
165: Vermeer SE, Hollander M, van Dijk EJ, et al. Silent brain infarcts and white matter lesions increase stroke risk in the general population: the Rotterdam Scan Study. Stroke 2003a;34(5):1126-9. PMID 12690219
166: Vermeer SE, Longstreth WT, Koudstaal PJ. Silent brain infarcts: a systematic review. Lancet Neurol 2007;6(7):611-9. PMID 17582361
167: Vermeer SE, Prins ND, den Heijer T, et al. Silent brain infarcts and the risk of dementia and cognitive decline. N Engl J Med 2003b;348(13):1215-22. PMID 12660385
168: Vinjamuri S, O'Driscoll K. Significance of white matter abnormalities in patients with closed head injury. Nucl Med Commun 2000;21(7):645-9. PMID 10994668
169: Vogt NM, Hunt JF, Ma Y, et al. Effects of simvastatin on white matter integrity in healthy middle-aged adults. Ann Clin Transl Neurol 2021;8(8):1656-67. PMID 34275209
170: Waldemar G, Christiansen P, Larsson HB, et al. White matter magnetic resonance hyperintensities in dementia of the Alzheimer type: morphological and regional cerebral blood flow correlates. J Neurol Neurosurg Psychiatry 1994;57:1458-65. PMID 7798973
171: Wardlaw JM, Sandercock PA, Dennis MS, Starr J. Is breakdown of the blood-brain barrier responsible for lacunar stroke, leukoaraiosis, and dementia? Stroke 2003;34(3):806-12. PMID 12624314
172: Whitman GT, DiPatre PL, Lopez IA, Liu F, Noori NE, Vinters HV, Baloh RW. Neuropathology in older people with disequilibrium of unknown cause. Neurology 1999;53(2):375-82. PMID 10430429
173: Whitman GT, Tang Y, Lin A, Baloh RW, Tang T. A prospective study of cerebral white matter abnormalities in older people with gait dysfunction. Neurology 2001;57(6):990-4. PMID 11571322
174: Wilson RS, Bennett D, Fox JH, et al. Alzheimer's disease: prevalence and clinical significance of white-matter lesions on magnetic resonance imaging. Ann Neurol 1988;24:160-1.
175: Wolf H, Ecke GM, Bettin S, Dietrich J, Gertz HJ. Do white matter changes contribute to the subsequent development of dementia in patients with mild cognitive impairment. A longitudinal study. Int J Geriatr Psychiatry 2000;15:803-12. PMID 10984726
176: Wolfe N, Linn R, Babikian VL, Knoefel JE, Albert ML. Frontal systems impairment following multiple lacunar infarcts. Arch Neurol 1990;47(2):129-32. PMID 2302084
177: Wolfson L, Wei X, Hall CB, et al. Accrual of MRI white matter abnormalities in elderly with normal and impaired mobility. J Neurol Sci 2005;232(1-2):23-7. PMID 15850578
178: Wong TY, Klein R, Sharrett AR, et al. Atherosclerosis risk in communities study. Cerebral white matter lesions, retinopathy, and incident clinical stroke. JAMA 2002;288(1):67-74. PMID 12090864
179: Xie L, Kang H, Xu Q, et al. Sleep drives metabolite clearance from the adult brain. Science 2013;342(6156):373-7. PMID 24136970
180: Xiong Y, Wong A, Cavalieri M, et al. Prestroke statins, progression of white matter hyperintensities, and cognitive decline in stroke patients with confluent white matter hyperintensities. Neurotherapeutics 2014;11(3):606-11. PMID 24692001
181: Xu MS, Tan CB, Umapathi T, Lim CC. Susac syndrome: serial diffusion-weighted MR imaging. Magn Reson Imaging 2004;22(9):1295-8. PMID 15607101
182: Ylikoski R, Ylikoski A, Erkinjuntti T, Sulkava R, Raininko R, Tilvis R. White matter changes in healthy elderly persons correlate with attention and speed of mental processing. Arch Neurol 1993;50:818-24. PMID 8352667
183: Zhang H, Cui Y, Zhao Y, et al. Effects of sartans and low-dose statins on cerebral white matter hyperintensities and cognitive function in older patients with hypertension: a randomized, double-blind and placebo-controlled clinical trial. Hypertens Res 2019;42(5):717-29. PMID 30552406
184: Zingel R, Bohlken J, Riedel-Heller S, Barth S, Kostev K. Association between low-density lipoprotein cholesterol levels, statin use, and dementia in patients followed in german general practices. J Alzheimers Dis 2021;79(1):37-46. PMID 33216039
185: Zeumer H, Schonsky B, Sturm KW. Predominant white matter involvement in subcortical arteriosclerotic encephalopathy (Binswanger disease). J Comput Assist Tomogr 1980;4(1):14-9. PMID 7354170

This is an article preview.
Start a Free Account
to access the full version.

Nearly 3,000 illustrations, including video clips of neurologic disorders.
Every article is reviewed by our esteemed Editorial Board for accuracy and currency.
Full spectrum of neurology in 1,200 comprehensive articles.
Listen to MedLink on the go with Audio versions of each article.

Questions or Comment?

MedLink®, LLC

3525 Del Mar Heights Rd, Ste 304
San Diego, CA 92130-2122

Toll Free (U.S. + Canada): 800-452-2400

US Number: +1-619-640-4660

Support: service@medlink.com

Editor: editor@medlink.com

ISSN: 2831-9125

White matter abnormalities in the brain

Associated Disorders

Adrenoleukodystrophy
AIDS-related dementia
Alzheimer disease
cytomegalovirus infection
dementia
- diabetes
- diabetes mellitus
- hypertension
- Kearns-Sayre syndrome
- Krabbe disease (globoid cell leukodystrophy)
- lacunar stroke
- Leigh disease (subacute necrotizing encephalomyelopathy)
- metachromatic leukodystrophy
- migraine
- mitochondrial encephalopathy with lactic acidosis and stroke-like episodes (MELAS)
- myotonic dystrophy
- pediatric dysmyelinating disorders
- pyridoxine deficiency
- stroke
- Susac syndrome
- vascular dementia

Differential Diagnosis

multiple sclerosis
Sjögren disease
Due to the ubiquitous nature of white matter abnormalities, the differential diagnosis is large.

Also Relevant

Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL)
Executive dysfunction
HIV-associated dementia
Pyridoxine-dependent epilepsy
Vascular dementia

	• Up to 80% of elderly individuals have white matter abnormalities.
	• The burden of white matter abnormalities increases with age.
	• Cerebrovascular risk factors and disease increase the risk of white matter abnormalities.
	• African Americans have a lower burden of white matter abnormalities than European Americans.

	• Brain CT identifies white matter lesions as hypodensities.
	• Brain MRI is more sensitive to the presence of white matter abnormalities than CT.
	• MRI can better differentiate white matter abnormalities from lacunes and enlarged perivascular spaces.

	• There is no treatment for white matter abnormalities.
	• The benefits of controlling the vascular risk factors should be weighed against the potential side effects of any intervention.

White matter abnormalities in the brain

Introduction

Overview

Key points

Historical note and terminology

Clinical manifestations

Presentation and course

Prognosis and complications

Clinical vignette

Biological basis

Pathophysiology

Genetics

Race

Age

Additional risk factors

Epidemiology

Prevention

Differential diagnosis

Confusing conditions

Associated or underlying disorders

Diagnostic workup

Management

Outcomes

Special considerations

Pregnancy

Anesthesia

Media

References

Contributors

Author

Editor

Former Authors

Patient Profile

ICD & OMIM codes

This is an article preview. Start a Free Account to access the full version.

Questions or Comment?

Also in This Category

Abnormalities of tetrahydrobiopterin metabolism

Carnitine palmitoyltransferase II deficiency

Aicardi-Goutieres syndrome

Cockayne syndrome

Rostral brainstem and thalamic infarctions

Methylmalonic acidemia

Aortic diseases: neurologic complications

HHH syndrome

This is an article preview.
Start a Free Account
to access the full version.